Register

[google-translator]

[contact-form-7 id="26" title="Speaker"]

Cardiovascular Impact of SGLT2 Inhibitors, RAS Inhibitors, and ARN Inhibitors in Heart Failure

June 20, 2023June 27, 2023 post date
by asif
Medishorts

Post navigation

Incorporating Patient-Reported Outcomes in Heart Failure: Bridging the Gap between Clinical Trials and Everyday Practice

Efficacy of Sacubitril/Valsartan Compared to Valsartan on Left Atrial Volume in Patients with Pre-Heart Failure

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Search

Recent Posts

Reconsidering the four pillars of therapy for HFrEF
Assessing the impact of ARNI introduction on the requirement fordevice therapy in heart failure
Real world retrospective study
Cardiovascular impact of sodium glucose cotransporter 2
Cardiovascular Disease Management in Individuals with Diabetes

Recent Comments

A WordPress Commenter on Hello world!

Archives

January 2024
November 2023
July 2023
June 2023

Categories

Abstract
Guidelines
Journal Scan
Medishorts
Uncategorized

© 2024. DocMode Health Technologies Limited. All rights reserved